Literature DB >> 15384930

Public health perspectives on generalized anxiety disorder.

Murray B Stein1.   

Abstract

Generalized anxiety disorder (GAD) is a chronic condition characterized by worry and concomitant anxiety symptoms that cause extreme distress and/or interfere with function. The 12-month prevalence of GAD in the general population ranges in studies from approximately 2% to 5%, with the majority of cases occurring comorbid with major depression. GAD is particularly prevalent in certain special populations, such as older adults, in whom it is the most common anxiety disorder. In clinical and community studies, GAD emerges as a strong predictor of functional impairment, over and above that explained by major depression. These observations lead to the conclusion that current public health efforts focused on identification and treatment of major depression should be extended to include GAD and other anxiety disorders.

Entities:  

Mesh:

Year:  2004        PMID: 15384930

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  7 in total

1.  Effects of eszopiclone and zolpidem on sleep-wake behavior, anxiety-like behavior and contextual memory in rats.

Authors:  Max P Huang; Kushan Radadia; Brian W Macone; Sanford H Auerbach; Subimal Datta
Journal:  Behav Brain Res       Date:  2010-02-12       Impact factor: 3.332

Review 2.  Interoception in anxiety and depression.

Authors:  Martin P Paulus; Murray B Stein
Journal:  Brain Struct Funct       Date:  2010-05-21       Impact factor: 3.270

3.  A community epidemiological survey of generalized anxiety disorder in Hong Kong.

Authors:  Sing Lee; Adley Tsang; Helena Chui; Kathleen Kwok; Emily Cheung
Journal:  Community Ment Health J       Date:  2007-03-01

4.  Does presence of metabolic syndrome impact anxiety and depressive disorder screening results in middle aged and elderly individuals? A population based study.

Authors:  Jurate Butnoriene; Vesta Steibliene; Ausra Saudargiene; Adomas Bunevicius
Journal:  BMC Psychiatry       Date:  2018-01-08       Impact factor: 3.630

5.  Risk Factors, Clinical Presentations, and Functional Impairments for Generalized Anxiety Disorder in Military Personnel and the General Population in Canada.

Authors:  Tamara L Taillieu; Tracie O Afifi; Sarah Turner; Kristene Cheung; Janique Fortier; Mark Zamorski; Jitender Sareen
Journal:  Can J Psychiatry       Date:  2018-01-05       Impact factor: 4.356

6.  The metabolic responses to aerial diffusion of essential oils.

Authors:  Yani Wu; Yinan Zhang; Guoxiang Xie; Aihua Zhao; Xiaolan Pan; Tianlu Chen; Yixue Hu; Yumin Liu; Yu Cheng; Yi Chi; Lei Yao; Wei Jia
Journal:  PLoS One       Date:  2012-09-12       Impact factor: 3.240

7.  Generalised anxiety disorder and hospital admissions: findings from a large, population cohort study.

Authors:  Olivia Remes; Nicholas Wainwright; Paul Surtees; Louise Lafortune; Kay-Tee Khaw; Carol Brayne
Journal:  BMJ Open       Date:  2018-10-27       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.